Segmenting "software-focused" strategist coverage from the TAMP platforms creates space for innovative portfolios to shine in the giants' trillion-dollar shadow

BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states

TAM's products are engineered to combat the low yield, low growth, high volatility challenges facing today's investors. We strive to educate our clients on current market risks and why portfolio shifts in stance are occurring.

Nationwide Children's Hospital and Families of Spinal Muscular Atrophy announce the award of a multi-million dollar cooperative agreement from the NINDS to advance a gene therapy development program for Spinal Muscular Atrophy.

The primary objectives of the study are to further evaluate the safety and plasma pharmacokinetics (PK) of multiple doses of RG3039 in healthy volunteers.

ClarySolar: the San Diego Based solar design and installation firm joined the elite group of the top 500 private companies in the US. The Inc. Magazine in its recent publication ranked ClarySolar 295th on the "Inc.500" list in 2012.

Families of Spinal Muscular Atrophy (FSMA) is dedicated to creating a treatment and cure for Spinal Muscular Atrophy (SMA) by funding and advancing a comprehensive research program

Families of SMA is pleased to announce the award of up to $750,000 for an important new grant to Dr. Brian Kaspar at Nationwide Children's Hospital.

With the 9th Annual Jacob's Run, Walk & Roll Event to be held on April 1st, The Jacob Isaac Rappoport Foundation is aiming to reach the milestone of raising $1,000,000 for Spinal Muscular Atrophy (SMA) Research

"Nutrition Basics: Fostering Health and Growth for Spinal Muscular Atrophy" is Families of SMA's newest release of the SMA Care Series Booklets.

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA). Isis is developing ISIS-SMNRx as a potential treatment for all types of SMA.

Awards will help develop new approaches for SMA therapies. These new awards encompass $745,000 for the basic research portion of the $3 Million in new research funding that FSMA announced earlier this year.

The new funding awards will be allocated into three distinct research areas: 1)Basic Research to understand the disease, 2)Drug Discovery to develop new SMA therapies, and 3)Clinical Research to provide the means to test new drugs effectively.

First ever clinical trial approved for SMA with a novel drug specifically designed to treat the disease.

Boynton Beach residents Shaina and Adi Rappoport have served as the event organizers since 2002 when their son, Jacob, passed way from SMA (Spinal Muscular Atrophy) related complications. Jacob was nine months old.

In response to our October Request for Proposals (RFP) for new drug programs to develop therapies for Spinal Muscular Atrophy we received nine Letters of Intent for potential programs.

The MDA has committed to invest funds in the FSMA Quinazoline Program at Repligen Corporation to assist in advancing the program to an IND filing with the FDA.

Families of SMA announces Request for Proposals (RFP) for new drug programs to develop therapies for Spinal Muscular Atrophy.
FSMA is aiming to fund two new preclinical drug development programs in 2011, with more to follow.

Planet Gift Baskets supports the annual fund raiser for Spinal Muscular Atrophy and family support.

Fashion show (25/10/10)hosted by TVs Jonathan Phang and Channel 4s Jon Snow (& including other celebs). To show that people with disabilities can follow fashion, display individuality and have sex appeal. All funds to go to the Jennifer Trust for SMA

All across the United States volunteers will come together to raise funds for critical SMA research and patient support programs. These events range from the FSMA signature Walk-n-Roll, to golf outings and fun comedy nights.